TY - STD TI - Simeoni M, Magni P, Cammia C, De Nicolao G, Croci V, Pesenti E, Germani M, Poggesi I, Rocchetti M. Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res. 2004;64:1094–11. ID - ref1 ER - TY - STD TI - Magni P, Simeoni M, Poggesi I, et al. A mathematical model to study the effects of drug administration on tumor growth dynamics. Math Biosci. 2006;200:127–51. ID - ref2 ER - TY - STD TI - Simeoni M, De Nicolao G, Magni P, et al. Modeling of human tumor xenographs and dose rationale in oncology. Drug Discov Today Technol. 2013;10:e365–72. ID - ref3 ER - TY - JOUR AU - Rocchetti, M. AU - Bene, F. AU - Germani, M. AU - Fiorentini, F. AU - Poggesi, I. AU - Pesenti, E. AU - Magni, P. AU - Nicolao, G. PY - 2009 DA - 2009// TI - Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approach JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2009.09.025 DO - 10.1016/j.ejca.2009.09.025 ID - Rocchetti2009 ER - TY - JOUR AU - Zhou, R. AU - Mazurchuk, R. V. AU - Tamburlin, J. H. AU - Harrold, J. M. AU - Mager, D. E. AU - Straubinger, R. M. PY - 2010 DA - 2010// TI - Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model JO - J Pharmacol Exp Ther VL - 332 UR - https://doi.org/10.1124/jpet.109.160044 DO - 10.1124/jpet.109.160044 ID - Zhou2010 ER - TY - STD TI - Terranova N, Germani M, Del Bene F, Magni P. A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination. Cancer Chemother Pharmacol. 2013;72:471–82. ID - ref6 ER - TY - JOUR AU - Li, J. Y. AU - Ren, Y. P. AU - Yuan, Y. AU - Ji, S. M. AU - Zhou, S. P. AU - Wang, L. J. AU - Mou, Z. Z. AU - Li, L. AU - Lu, W. AU - Zhou, T. Y. PY - 2016 DA - 2016// TI - Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice JO - Acta Pharmacol Sin VL - 37 UR - https://doi.org/10.1038/aps.2016.55 DO - 10.1038/aps.2016.55 ID - Li2016 ER - TY - JOUR AU - Pigatto, M. C. AU - Roman, R. M. AU - Carrara, L. AU - Buffon, A. AU - Magni, P. AU - Dalla, C. T. PY - 2017 DA - 2017// TI - Pharmacokinetic/pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker−256 tumor-bearing rat model using free intratumoral drug concentrations JO - Eur J Pharm Sci VL - 97 UR - https://doi.org/10.1016/j.ejps.2016.10.038 DO - 10.1016/j.ejps.2016.10.038 ID - Pigatto2017 ER - TY - JOUR AU - Yates, J. W. T. AU - Holt, S. V. AU - Armelle Logie, A. PY - 2017 DA - 2017// TI - A pharmacokinetic–pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055 JO - Br J Pharmacol VL - 174 UR - https://doi.org/10.1111/bph.13886 DO - 10.1111/bph.13886 ID - Yates2017 ER - TY - STD TI - Benzekry S, Lamont C, Beheshti A, et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014;10:e1003800. ID - ref10 ER - TY - STD TI - Delyon B, Lavielle M, Moulines E. Convergence of a stochastic approximation version of the EM algorithm. Ann Stat. 1999;27:94–128. ID - ref11 ER - TY - STD TI - Comets E, Lavenu A, Lavielle M. Parameter estimation in nonlinear mixed effect models using saemix,an R implementation of the SAEM algorithm. Journal of Statistical Software. 2017. https://doi.org/10.18637/jss.v080.i03. ID - ref12 ER - TY - STD TI - Sugiura N. Further analysis of the data by Akaike’s information criterion and the finite corrections. Communications in Statistics, Theory and Methods. 1978;7:13–26. ID - ref13 ER - TY - STD TI - Hurvich CM, Tsai C-L. Model selection for extended quasi-likelihood models in small samples. Biometrics. 1995;51:1077–84. ID - ref14 ER - TY - STD TI - Burnham KP, Anderson DR. Model selection and multi model inference: A practical information-theoretic approach. New York: Springer-Verlag; 2002. ID - ref15 ER - TY - JOUR AU - Akaike, H. PY - 1974 DA - 1974// TI - On the likelihood of a time series model JO - The Statistician VL - 27 UR - https://doi.org/10.2307/2988185 DO - 10.2307/2988185 ID - Akaike1974 ER - TY - JOUR AU - Wagenmakers, E. -. J. AU - Farrell, S. PY - 2004 DA - 2004// TI - AIC model selection using Akaike weights JO - Psychon Bull Rev VL - 11 UR - https://doi.org/10.3758/BF03206482 DO - 10.3758/BF03206482 ID - Wagenmakers2004 ER - TY - STD TI - Mould DR, Walz A-C, Lave T, Gibbs JP, Frame B. Developing exposure/response models for anticancer drug treatment: special considerations. CPT Pharmacometrics Syst Pharmacol. 2015;4:12–27. ID - ref18 ER - TY - STD TI - Villasana M, Radunskaya A. A delay differential equation model for tumor growth. J Math Biol. 2003;47:270–94. ID - ref19 ER - TY - STD TI - Cui S, Xu S. Analysis of mathematical models for the growth of tumors with time delays in cell proliferation. J Math Anal Appl. 2007;336:523–41. ID - ref20 ER - TY - STD TI - Bodnar M, Piotrowska MJ, Forys U. Gompertz model with delays and treatment: mathematical analysis. Math Biosci Eng. 2013;10:551–63. ID - ref21 ER - TY - STD TI - Xu S, Wei X, Zhang F. A time-delayed mathematical model of tumor growth with the effect of a periodic therapy. Comput Math Methods Med. 2016;2016:3643019. ID - ref22 ER - TY - STD TI - Mazlan MSA, Rosli N, Azmi NS. Modelling the cancer growth process by stochastic delay differential equations under Verhults and Gompertz’s law. Jurnal Teknologi. 2016;78:77–82. ID - ref23 ER - TY - STD TI - Kim PS, Lee PP. Modeling protective anti-tumor immunity via preventable cancer vaccines using a hybrid agent-based and delay differential equation approach. PLoS Comput Biol. 2012;8:e1002742. ID - ref24 ER - TY - STD TI - El-Kareh AW, Secomb TW. A mathematical model for cisplatin cellular pharmacodynamics. Neoplasia. 2003;5:161–9. ID - ref25 ER - TY - STD TI - Ribba B, Watkin E, Tod M, et al. A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers. Eur J Cancer. 2011;47:479–90. ID - ref26 ER - TY - STD TI - Ribba B, Kaloshi G, Peyre M, et al. A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy. Clin Cancer Res. 2012;18:5071–80. ID - ref27 ER - TY - STD TI - Ribba B, Holford NH, Magni P, et al. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis. CPT Pharmacometrics Syst Pharmacol. 2014;3:e113. ID - ref28 ER -